Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood Test

Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis

NCT02277574 ·Status: COMPLETED ·Phase: PHASE1

Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate

NCT00069017 ·Status: COMPLETED ·Phase: PHASE2

Usability of an AI for M923 in Subjects With Moderate to Severe RA

NCT02722044 ·Status: COMPLETED ·Phase: PHASE3

A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis

NCT06857227 ·Status: RECRUITING ·Phase: PHASE1

Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

NCT00837434 ·Status: COMPLETED ·Phase: PHASE4

Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)

NCT06333210 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Tocilizumab to Treat Polymyalgia Rheumatica

NCT01396317 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of AMG 827 in Subjects With RA

NCT01059448 ·Status: TERMINATED ·Phase: PHASE2

Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept

NCT02353780 ·Status: TERMINATED ·Phase: PHASE4

Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis

NCT03233230 ·Status: COMPLETED ·Phase: PHASE2

A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate

NCT00266227 ·Status: COMPLETED ·Phase: PHASE3

Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

NCT00116714 ·Status: COMPLETED

An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct)

NCT01483326 ·Status: COMPLETED

Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel

NCT03082573 ·Status: UNKNOWN ·Phase: PHASE4

Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging

NCT02683421 ·Status: COMPLETED ·Phase: PHASE1

Faecal Analyses in Spondyloarthritis Therapy

NCT03839862 ·Status: RECRUITING

A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects

NCT02198651 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis

NCT00771030 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)

NCT00380601 ·Status: COMPLETED ·Phase: PHASE3

U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)

NCT01918267 ·Status: COMPLETED

Using Adalimumab Serum Concentration to Choose a Subsequent Biological DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment

NCT04251741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy

NCT00689728 ·Status: COMPLETED ·Phase: PHASE2

COVID-19 Vaccination in Rheumatic Disease Patients

NCT04839315 ·Status: TERMINATED ·Phase: EARLY_PHASE1

An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs

NCT01388309 ·Status: COMPLETED

The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection

NCT07001956 ·Status: RECRUITING ·Phase: EARLY_PHASE1